Literature DB >> 22938785

Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.

Bryan C Duffy1, Lei Zhu, Hélène Decornez, Douglas B Kitchen.   

Abstract

Early drug discovery processes rely on hit finding procedures followed by extensive experimental confirmation in order to select high priority hit series which then undergo further scrutiny in hit-to-lead studies. The experimental cost and the risk associated with poor selection of lead series can be greatly reduced by the use of many different computational and cheminformatic techniques to sort and prioritize compounds. We describe the steps in typical hit identification and hit-to-lead programs and then describe how cheminformatic analysis assists this process. In particular, scaffold analysis, clustering and property calculations assist in the design of high-throughput screening libraries, the early analysis of hits and then organizing compounds into series for their progression from hits to leads. Additionally, these computational tools can be used in virtual screening to design hit-finding libraries and as procedures to help with early SAR exploration.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938785     DOI: 10.1016/j.bmc.2012.04.062

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  Computational models for neglected diseases: gaps and opportunities.

Authors:  Elizabeth L Ponder; Joel S Freundlich; Malabika Sarker; Sean Ekins
Journal:  Pharm Res       Date:  2013-08-30       Impact factor: 4.200

Review 2.  Novel approaches to pulmonary arterial hypertension drug discovery.

Authors:  Yon K Sung; Ke Yuan; Vinicio A de Jesus Perez
Journal:  Expert Opin Drug Discov       Date:  2016-02-27       Impact factor: 6.098

3.  Computer-aided drug discovery research at a global contract research organization.

Authors:  Douglas B Kitchen
Journal:  J Comput Aided Mol Des       Date:  2016-11-01       Impact factor: 3.686

Review 4.  Phenotypic Screens in Antimalarial Drug Discovery.

Authors:  Marisa L Hovlid; Elizabeth A Winzeler
Journal:  Trends Parasitol       Date:  2016-05-27

5.  Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis.

Authors:  Sean Ekins; Allen C Casey; David Roberts; Tanya Parish; Barry A Bunin
Journal:  Tuberculosis (Edinb)       Date:  2013-12-19       Impact factor: 3.131

6.  Accurate acid dissociation constant (pKa) calculation for the sulfachloropyridazine and similar molecules.

Authors:  Fernando Marques Carvalho; Yuri Alves de Oliveira Só; Alessandra Sofia Kiametis Wernik; Mônica de Abreu Silva; Ricardo Gargano
Journal:  J Mol Model       Date:  2021-07-29       Impact factor: 1.810

7.  Rapid scanning structure-activity relationships in combinatorial data sets: identification of activity switches.

Authors:  José L Medina-Franco; Bruce S Edwards; Clemencia Pinilla; Jon R Appel; Marc A Giulianotti; Radleigh G Santos; Austin B Yongye; Larry A Sklar; Richard A Houghten
Journal:  J Chem Inf Model       Date:  2013-06-07       Impact factor: 4.956

Review 8.  The essential roles of chemistry in high-throughput screening triage.

Authors:  Jayme L Dahlin; Michael A Walters
Journal:  Future Med Chem       Date:  2014-07       Impact factor: 3.808

9.  A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics.

Authors:  Pramod Rajaram Somvanshi; K V Venkatesh
Journal:  Syst Synth Biol       Date:  2013-09-18

10.  QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni.

Authors:  Cleber C Melo-Filho; Rafael F Dantas; Rodolpho C Braga; Bruno J Neves; Mario R Senger; Walter C G Valente; João M Rezende-Neto; Willian T Chaves; Eugene N Muratov; Ross A Paveley; Nicholas Furnham; Lee Kamentsky; Anne E Carpenter; Floriano P Silva-Junior; Carolina H Andrade
Journal:  J Chem Inf Model       Date:  2016-06-16       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.